| Products Vitacon currently markets three information products: In-Licensing Gems: Oncology is our business intelligence report series that focuses on current in-licensing opportunities for oncology drugs in early development. Discover promising opportunities against validated and novel targets that are well-tolerated, potentially efficacious, and currently unpartnered. Please see sample pages of our report here. Vitacon Drug Valuation Model™ is our asset valuation and transaction strategy tool. Analyze the risk-adjusted value of your new drug using a sensible number of input estimates and explore the deal structure that could satisfy any one of three starting points for a licensing bid. For more information click here. PharmInt™ is a suite of marketed drug product intelligence reports. PharmInt™ is focused on launched drugs and is updated quarterly to include information on general molecular information about the compound/biologic, safety/efficacy information, formulary status, adverse events, product sales, ongoing clinical trials, and other product-relevant news. The drug reports are available as a subscription on a quarterly basis. For more information click here. If you wish to purchase any of our products, please send an inquiry to bizdev@vitaconsult.net. |
| 2008-2010 Vitacon LLC. All rights reserved. Vitacon Health is a division of Vitacon LLC |
Vitacon Health
 |  |  |  |
